Crescita Therapeutics IncCrescita Therapeutics Inc - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

This report of Crescita Therapeutics Inc employs data from across the internet and also from available filings by Crescita Therapeutics Inc. The ESG score includes 17 UN Sustainable Development Goals including: 'Gender Equality', 'Reduced Inequalities' and 'Peace, Justice & Strong Institutions'. Browse to the end of this page for potential risks for Crescita Therapeutics Inc based on sector, geography and size.

Crescita Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.1; made up of an environmental score of 8.0, social score of 8.0 and governance score of 5.3.

SDG Transparency Score for Crescita Therapeutics Inc 
Low
0 - 3
Medium
4 - 6

7.1

High Impact
7 - 10
Last Score Update: 2024-05-01
What drives the score for Crescita Therapeutics Inc 
8.0

Environmental

8.0

Social

5.3

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Caladrius Biosciences Inc
8.0
High
1Can Fite Biopharma Ltd
8.0
High
217Takara Bio Inc
7.2
High
217Ultragenyx Pharmaceutical Inc
7.2
High
224Crescita Therapeutics Inc
7.1
High
224Celularity Inc
7.1
High
224Bilcare Ltd
7.1
High
.........
1970Zyden Gentec Ltd
0.0
Low
1970iNtRON Biotechnology Inc
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Crescita Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Crescita Therapeutics Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Crescita Therapeutics Inc report the average age of the workforce?

LockedSign up for free to unlock

Does Crescita Therapeutics Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Crescita Therapeutics Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Crescita Therapeutics Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does Crescita Therapeutics Inc offer flexible work?

LockedSign up for free to unlock

Does Crescita Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Crescita Therapeutics Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Crescita Therapeutics Inc conduct supply chain audits?

LockedSign up for free to unlock

Does Crescita Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Crescita Therapeutics Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Crescita Therapeutics Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Crescita Therapeutics Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Crescita Therapeutics Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Crescita Therapeutics Inc disclose water use targets?

LockedSign up for free to unlock

Does Crescita Therapeutics Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Crescita Therapeutics Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does Crescita Therapeutics Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does Crescita Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Crescita Therapeutics Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Crescita Therapeutics Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does Crescita Therapeutics Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Crescita Therapeutics Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Crescita Therapeutics Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Crescita Therapeutics Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Crescita Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Crescita Therapeutics Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Crescita Therapeutics Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Crescita Therapeutics Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Crescita Therapeutics Inc disclose its waste policy?

LockedSign up for free to unlock

Does Crescita Therapeutics Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does Crescita Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Crescita Therapeutics Inc disclose energy use targets?

LockedSign up for free to unlock

Does Crescita Therapeutics Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Crescita Therapeutics Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Crescita Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.

Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including MMPE and DuraPeel for the development of topicals containing cannabis and hemp. The company's prescription products include Pliaglis, a topical local anesthetic cream that provides dermal analgesia on intact skin prior to superficial dermatological procedures; CTX-101, a Phase III topical formulation utilizing a corticosteroid in combination with MMPE technology to treat plaque psoriasis; CTX-102, a Phase I topical formulation utilizing MMPE technology to treat an undisclosed dermatological skin condition; and dermatology products in pre-clinical formulation utilizing MMPE technology for prescription treatments of skin diseases. Its non-prescription skincare products comprise skincare products, such as facial creams, cleansers, exfoliants, masks, serums, and suncare products for aging, acne, rosacea, pigmentation, dehydration, and sensitivity under the Laboratoire Dr Renaud brand; a line of dermocosmetic products for anti-aging medical procedures under the Pro-Derm brand; a line of products to target and treat various skincare concerns under the Alyria brand; and skincare products primarily for the Asian consumers under Dermazulene brand, as well as NCTF 135 HA, a skin revitalization solution primarily used for the improvement of skin quality and fine lines. The company has a development and licensing agreement with Sundial Growers Inc. to develop cannabis; a commercialization license agreement with Cantabria Labs Inc.; and a development and commercialization license agreement with Taro Pharmaceuticals Inc. Crescita Therapeutics Inc. was incorporated in 2016 and is headquartered in Laval, Canada.

Sorry!

Failed to process!